NCT02865343

Brief Summary

The investigators have an existing exercise program (N\>70) with a unique population of individuals with spinal cord injury (SCI) who have been enrolled in FES-RT for at least 6 months. Roughly half have high level SCI. Thirty individuals with high level SCI who have FES-row trained for at least 6 months will be randomized to (continued) FES-RT for 3 months with either NIV or sham NIV. Before and after training, the investigators will assess maximal aerobic capacity, ventilation, cardiac output, and arterio-venous oxygen difference. Based on the investigators current data, it is hypothesized that only those randomized to NIV will experience further increases in aerobic capacity and that these increases will relate to increases in cardiac output and arterio-venous oxygen difference. This Exploratory/Developmental Research project will lay the groundwork for a larger study of the impact of FES-RT+NIV to improve health and function in those with high level SCI.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
11

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Feb 2017

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

July 15, 2016

Completed
28 days until next milestone

First Posted

Study publicly available on registry

August 12, 2016

Completed
6 months until next milestone

Study Start

First participant enrolled

February 22, 2017

Completed
2.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 28, 2019

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 28, 2019

Completed
1.1 years until next milestone

Results Posted

Study results publicly available

July 30, 2020

Completed
Last Updated

February 9, 2023

Status Verified

February 1, 2023

Enrollment Period

2.3 years

First QC Date

July 15, 2016

Results QC Date

June 15, 2020

Last Update Submit

February 8, 2023

Conditions

Keywords

Functional Electrical Stimulation (FES)-Rowing

Outcome Measures

Primary Outcomes (1)

  • Change in Baseline Aerobic Capacity After 3 Months of FES-row Training.

    Volunteers will perform a maximal incremental FES-row tests. Both NIV Support and Sham-NIV groups will perform tests in the Sham-NIV condition

    Baseline and 3 months

Secondary Outcomes (2)

  • Change in Peak Cardiac Output After 3 Months of FES-row Training.

    Baseline and 3 months

  • Change in Baseline Peak Minute Ventilation During Exercise After 3 Months of FES-row Training

    Baseline and 3 months

Study Arms (2)

Non-invasive Ventilation(NIV)

ACTIVE COMPARATOR

Subjects randomized to NIV will perform 12-weeks of FES-row training while receiving bi-level positive airway pressure ventilation applied through a full face-mask.

Device: Non-invasive Ventilation(NIV)

Sham Non-invasive ventilation(NIV)

PLACEBO COMPARATOR

Subjects randomized to Sham-NIV will perform 12-weeks of FES-row training while receiving sham ventilation applied through a full face-mask.

Device: Sham Non-invasive ventilation(NIV)

Interventions

The ventilator will be set in spontaneous mode with a ramp to reach a minimal pressure of 12 centimeters of water (cmH2O) during inspiration and 3 cmH2O during expiration.

Non-invasive Ventilation(NIV)

The ventilator will be set in spontaneous mode with a ramp to reach a maximal pressure of 5 centimeters of water (cmH2O) during inspiration and 3 cmH2O during expiration.

Sham Non-invasive ventilation(NIV)

Eligibility Criteria

Age18 Years - 60 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • Subjects aged 18 to 60
  • Have had high level SCI (neurological level ≥T3 with American Spinal Injury Association grade A or B or C)
  • Medically stable
  • Have FES-row trained for \>6 months

You may not qualify if:

  • Hypertension(Blood pressure\>140/90 mmHg)
  • Significant arrhythmias
  • Coronary disease
  • Chronic respiratory disease
  • Diabetes
  • Renal disease
  • Cancer
  • Epilepsy
  • Current use of cardioactive medications
  • Current grade 2 or greater pressure ulcers at relevant contact sites
  • Other neurological disease
  • Peripheral nerve compression or rotator cuff tears that limit the ability to row
  • History of bleeding disorder

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Spaulding Hospital Cambridge

Cambridge, Massachusetts, 02138, United States

Location

Related Publications (1)

  • Vivodtzev I, Picard G, Cepeda FX, Taylor JA. Acute Ventilatory Support During Whole-Body Hybrid Rowing in Patients With High-Level Spinal Cord Injury: A Randomized Controlled Crossover Trial. Chest. 2020 May;157(5):1230-1240. doi: 10.1016/j.chest.2019.10.044. Epub 2019 Nov 16.

MeSH Terms

Conditions

Spinal Cord Injuries

Interventions

Noninvasive Ventilation

Condition Hierarchy (Ancestors)

Spinal Cord DiseasesCentral Nervous System DiseasesNervous System DiseasesTrauma, Nervous SystemWounds and Injuries

Intervention Hierarchy (Ancestors)

Respiration, ArtificialAirway ManagementTherapeuticsRespiratory Therapy

Limitations and Caveats

The repeatability of maximal exercise tests is difficult in Spinal cord injury, increasing variability of measures an limiting data availability. Higher number of participants will be necessary to study the effect of NIV on the aerobic capacity.

Results Point of Contact

Title
Dr J. Andrew Taylor
Organization
Harvard Medical School

Study Officials

  • J. Andrew Taylor, PhD

    Spaulding Rehabilitation Hospital

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
No
Restrictive Agreement
No

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
QUADRUPLE
Who Masked
PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
Masking Details
Investigators and technicians helping for performing the test and encouraging the patient will be blind. Only one investigator will monitor the ventilation during the test and won't be blind but won't be participating to any encouragement or data acquisition.
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principle Investigator

Study Record Dates

First Submitted

July 15, 2016

First Posted

August 12, 2016

Study Start

February 22, 2017

Primary Completion

June 28, 2019

Study Completion

June 28, 2019

Last Updated

February 9, 2023

Results First Posted

July 30, 2020

Record last verified: 2023-02

Data Sharing

IPD Sharing
Will not share

Locations